METLIFE INC (MET) Stock Analyst Ratings
USA - NYSE:MET - US59156R1086 - Common Stock
75.97 USD
-2.71 (-3.44%)
75.97 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 80% to MET. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 96.75. This target is 27.36% above the current price.
MET was analyzed by 21 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about MET.
In the previous month the buy percentage consensus was at a similar level.
MET was analyzed by 21 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-06 | UBS | Maintains | Buy -> Buy |
| 2025-10-08 | Barclays | Maintains | Overweight -> Overweight |
| 2025-10-08 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-10-07 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-09-19 | Piper Sandler | Downgrade | Overweight -> Neutral |
| 2025-09-16 | Wolfe Research | Initiate | Outperform |
| 2025-08-18 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-08-11 | Keefe, Bruyette & Woods | Maintains | Outperform -> Outperform |
| 2025-08-11 | Jefferies | Maintains | Buy -> Buy |
| 2025-08-07 | UBS | Maintains | Buy -> Buy |
| 2025-07-14 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-07-10 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-07-09 | Keefe, Bruyette & Woods | Maintains | Outperform -> Outperform |
| 2025-07-08 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-07-07 | Barclays | Maintains | Overweight -> Overweight |
| 2025-05-19 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-05-06 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-04-11 | Barclays | Maintains | Overweight -> Overweight |
| 2025-04-10 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-04-10 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-04-09 | Keefe, Bruyette & Woods | Maintains | Outperform -> Outperform |
| 2025-04-02 | UBS | Maintains | Buy -> Buy |
| 2025-04-02 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-04-02 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-02-28 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-02-19 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-02-12 | Keefe, Bruyette & Woods | Maintains | Outperform -> Outperform |
| 2025-02-07 | Barclays | Maintains | Overweight -> Overweight |
| 2025-01-23 | BMO Capital | Initiate | Market Perform |
| 2025-01-14 | Wells Fargo | Maintains | Overweight -> Overweight |
METLIFE INC / MET FAQ
What is the price target for MET stock?
21 analysts have analysed MET and the average price target is 96.75 USD. This implies a price increase of 27.36% is expected in the next year compared to the current price of 75.97.
What is the consensus rating for METLIFE INC (MET) stock?
The consensus rating for METLIFE INC (MET) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.
What is the number of analysts for MET stock?
The number of analysts covering METLIFE INC (MET) is 21.